Literature DB >> 1103620

Gram-negative bacillary meningitis.

R J Mangi, R Quintiliani, V T Andriole.   

Abstract

All cases of unusual types of gram-negative bacillary meningitis in a university hospital over a five year period were retrospectively analyzed. These patients comprised 4.2 per cent of cases of bacterial meningitis among all patients, 69 per cent of neurosurgical cases and 42 per cent of neonatal cases. The over-all mortality was 40.3 per cent. The two most common bacterial isolates were Escherichia coli in patients younger than one year and Klebsiella species in patients above that age. Infection may be acquired at birth or at the time of surgery, or may be secondary to spread of infection from other body sites. Gram-negative bacillary meningitis is a nosocomial infection and this diagnosis should be suspected in patients in whom central nervous system infection develops in the hospital.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1103620     DOI: 10.1016/0002-9343(75)90468-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  20 in total

1.  Escherichia coli meningitis and disseminated strongyloidiasis.

Authors:  A J Thompson; M M Brown; A Ridley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

2.  Klebsiella oxytoca meningitis: frequent association with neurosurgical procedures.

Authors:  L M Tang; S T Chen
Journal:  Infection       Date:  1995 May-Jun       Impact factor: 3.553

3.  Enhanced in vitro bactericidal activity of amikacin or gentamicin combined with three new extended-spectrum cephalosporins against cephalothin-resistant members of the family Enterobacteriaceae.

Authors:  A S Bayer; R Eisenstadt; J O Morrison
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

Review 4.  Cephalosporins in adult meningitis.

Authors:  T R Beam
Journal:  Bull N Y Acad Med       Date:  1984-05

5.  Cerebrospinal fluid penetration of amikacin.

Authors:  D J Briedis; H G Robson
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

6.  Efficacy of Ceftaroline Fosamil against Escherichia coli and Klebsiella pneumoniae strains in a rabbit meningitis model.

Authors:  A Stucki; F Acosta; M Cottagnoud; P Cottagnoud
Journal:  Antimicrob Agents Chemother       Date:  2013-09-03       Impact factor: 5.191

7.  Cefotaxime in the treatment of meningitis.

Authors:  C E Cherubin; J LeFrock
Journal:  Infection       Date:  1985       Impact factor: 3.553

8.  Rapid differentiation of bacterial meningitides by direct gas-liquid chromatography.

Authors:  H Thadepalli; P K Gangopadhyay; A Ansari; G D Overturf; V K Dhawan; A K Mandal
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

9.  Comparison of netilmicin with gentamicin in the therapy of experimental Escherichia coli meningitis.

Authors:  W M Scheld; R S Brown; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

10.  Bacterial meningitis: epidemiology, pathogenesis and management update.

Authors:  Yuliya Nudelman; Allan R Tunkel
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.